Parkman Healthcare Partners LLC Aprea Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 12, 2021	SELL	$4.92 - $30.67 $98,606 - $614,688	-20,042 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$21.66 - $38.86 $433,070 - $776,966	-19,994 Reduced 49.94%	20,042 $482,000
Q2 2020 Aug 13, 2020	BUY	$25.47 - $39.69 $254,700 - $396,900	10,000 Added 33.29%	40,036 $1.55 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $45.3 $950,639 - $1.36 Million	30,036 New	30,036 $1.04 Million

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,688
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.